MD-960

N/A

Report date: 2025/06/11 20:01:15

NME

Base Information

Drug NameMD-960

Drug Alias Nameprotein tyrosine phosphatase inhibitors (Aus Bio)MD-960 Program (Aus Bio)PTP inhibitors (Aus Bio)Nitric Oxide Agonists (Aus Bio)Insulin Sensitizers (Aus Bio) +[8]

ClassificationSmall molecules

Mechanisms of ActionInsulin sensitizersProtein tyrosine phosphatase inhibitorsNitric oxide stimulants

TargetsProtein tyrosine phosphatase

Therapy Area/IndicationsDiabetes Mellitus

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryAustralia and New Zealand

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesAus Bio

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesAus Bio

Active IndicationsN/A

Inactive IndicationsDiabetes Mellitus

Other Information

ATC CodeN/A